Skip to main content
Erschienen in: Journal of Neurology 8/2010

01.08.2010 | Original Communication

Familial aggregation in atypical Parkinson’s disease: a case control study in multiple system atrophy and progressive supranuclear palsy

verfasst von: Jean-Sébastien Vidal, Marie Vidailhet, Pascal Derkinderen, Christophe Tzourio, Annick Alpérovitch

Erschienen in: Journal of Neurology | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Familial aggregation has been consistently found in PD, but it is unclear whether there is a familial aggregation in families of patients with multiple system atrophy (MSA) or progressive supranuclear palsy (PSP). MSA and PSP cases were recruited from a two-arm case control study. One control was matched to each case for age, gender and living area. Medical history of first-degree relatives was obtained through a face-to-face questionnaire. Age-specific cumulative incidence of Parkinsonism and dementia in first-degree relatives of cases and controls was compared for MSA and PSP separately. Seventy-one pairs for MSA and their controls and 79 pairs for PSP and their controls were included. No significant familial aggregation was found in PSP. MSA cases reported Parkinsonism more often, but not dementia in their first-degree relatives than controls. MSA patients, but not those with PSP, have Parkinsonism more often in their first-degree relatives than controls.
Literatur
1.
Zurück zum Zitat Autere JM, Moilanen JS, Myllyla VV, Majamaa K (2000) Familial aggregation of Parkinson’s disease in a Finnish population. J Neurol Neurosurg Psychiatry 69:107–109CrossRefPubMed Autere JM, Moilanen JS, Myllyla VV, Majamaa K (2000) Familial aggregation of Parkinson’s disease in a Finnish population. J Neurol Neurosurg Psychiatry 69:107–109CrossRefPubMed
2.
Zurück zum Zitat Borroni B, Del Bo R, Goldwurm S, Archetti S, Bonvicini C, Agosti C, Bigni B, Papetti A, Ghezzi S, Sacilotto G, Pezzoli G, Gennarelli M, Bresolin N, Comi GP, Padovani A (2010) VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome. J Alzheimers Dis Borroni B, Del Bo R, Goldwurm S, Archetti S, Bonvicini C, Agosti C, Bigni B, Papetti A, Ghezzi S, Sacilotto G, Pezzoli G, Gennarelli M, Bresolin N, Comi GP, Padovani A (2010) VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome. J Alzheimers Dis
3.
Zurück zum Zitat Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41:277–281CrossRefPubMed Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41:277–281CrossRefPubMed
4.
Zurück zum Zitat de Yebenes JG, Sarasa JL, Daniel SE, Lees AJ (1995) Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. Brain 118:1095–1103CrossRefPubMed de Yebenes JG, Sarasa JL, Daniel SE, Lees AJ (1995) Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. Brain 118:1095–1103CrossRefPubMed
5.
Zurück zum Zitat Elbaz A, McDonnell SK, Maraganore DM, Strain KJ, Schaid DJ, Bower JH, Ahlskog JE, Rocca WA (2003) Validity of family history data on PD: evidence for a family information bias. Neurology 61:11–17PubMed Elbaz A, McDonnell SK, Maraganore DM, Strain KJ, Schaid DJ, Bower JH, Ahlskog JE, Rocca WA (2003) Validity of family history data on PD: evidence for a family information bias. Neurology 61:11–17PubMed
6.
Zurück zum Zitat Gilman S, Low PA, Quinn N, Albanese A, Ben Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1998) Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 74:189–192PubMed Gilman S, Low PA, Quinn N, Albanese A, Ben Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1998) Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 74:189–192PubMed
7.
Zurück zum Zitat Golbe LI (1993) Progressive supranuclear palsy. In: Tolosa E (ed) Parkinson’s disease and movement disorders, 2nd edn. Williams & Wilkins, Baltimore, pp 145–161 Golbe LI (1993) Progressive supranuclear palsy. In: Tolosa E (ed) Parkinson’s disease and movement disorders, 2nd edn. Williams & Wilkins, Baltimore, pp 145–161
8.
Zurück zum Zitat Hara K, Momose Y, Tokiguchi S, Shimohata M, Terajima K, Onodera O, Kakita A, Yamada M, Takahashi H, Hirasawa M, Mizuno Y, Ogata K, Goto J, Kanazawa I, Nishizawa M, Tsuji S (2007) Multiplex families with multiple system atrophy. Arch Neurol 64:545–551CrossRefPubMed Hara K, Momose Y, Tokiguchi S, Shimohata M, Terajima K, Onodera O, Kakita A, Yamada M, Takahashi H, Hirasawa M, Mizuno Y, Ogata K, Goto J, Kanazawa I, Nishizawa M, Tsuji S (2007) Multiplex families with multiple system atrophy. Arch Neurol 64:545–551CrossRefPubMed
9.
Zurück zum Zitat Kaat LD, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC (2009) Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology 73:98–105CrossRefPubMed Kaat LD, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC (2009) Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology 73:98–105CrossRefPubMed
10.
Zurück zum Zitat Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124:1438–1449CrossRefPubMed Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124:1438–1449CrossRefPubMed
11.
Zurück zum Zitat Nee LE, Gomez MR, Dambrosia J, Bale S, Eldridge R, Polinsky RJ (1991) Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1:9–13CrossRefPubMed Nee LE, Gomez MR, Dambrosia J, Bale S, Eldridge R, Polinsky RJ (1991) Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1:9–13CrossRefPubMed
12.
Zurück zum Zitat Oliva R, Tolosa E, Ezquerra M, Molinuevo JL, Valldeoriola F, Burguera J, Calopa M, Villa M, Ballesta F (1998) Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol 55:1122–1124CrossRefPubMed Oliva R, Tolosa E, Ezquerra M, Molinuevo JL, Valldeoriola F, Burguera J, Calopa M, Villa M, Ballesta F (1998) Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol 55:1122–1124CrossRefPubMed
13.
Zurück zum Zitat Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, Quinn N (2002) Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 59:1486–1491CrossRefPubMed Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, Quinn N (2002) Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 59:1486–1491CrossRefPubMed
14.
Zurück zum Zitat R Foundation for Statistical Computing (2010) R Development Core Team (2009). R: a language and environment for statistical computing. Vienna, Austria R Foundation for Statistical Computing (2010) R Development Core Team (2009). R: a language and environment for statistical computing. Vienna, Austria
15.
Zurück zum Zitat Ros R, Thobois S, Streichenberger N, Kopp N, Sanchez MP, Perez M, Hoenicka J, Avila J, Honnorat J, de Yebenes JG (2005) A new mutation of the tau gene, G303 V, in early-onset familial progressive supranuclear palsy. Arch Neurol 62:1444–1450CrossRefPubMed Ros R, Thobois S, Streichenberger N, Kopp N, Sanchez MP, Perez M, Hoenicka J, Avila J, Honnorat J, de Yebenes JG (2005) A new mutation of the tau gene, G303 V, in early-onset familial progressive supranuclear palsy. Arch Neurol 62:1444–1450CrossRefPubMed
16.
Zurück zum Zitat Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Gasser T (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610–614CrossRefPubMed Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Gasser T (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610–614CrossRefPubMed
17.
Zurück zum Zitat Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354:1771–1775CrossRefPubMed Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354:1771–1775CrossRefPubMed
18.
Zurück zum Zitat Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H (2006) Heredity in multiple system atrophy. J Neurol Sci 240:107–110CrossRefPubMed Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H (2006) Heredity in multiple system atrophy. J Neurol Sci 240:107–110CrossRefPubMed
19.
Zurück zum Zitat Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH (1999) Environmental, medical, and family history risk factors for Parkinson’s disease: a New England-based case control study. Am J Med Genet 88:742–749CrossRefPubMed Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH (1999) Environmental, medical, and family history risk factors for Parkinson’s disease: a New England-based case control study. Am J Med Genet 88:742–749CrossRefPubMed
20.
Zurück zum Zitat Thacker EL, Ascherio A (2008) Familial aggregation of Parkinson’s disease: a meta-analysis. Mov Disord 23:1174–1183CrossRefPubMed Thacker EL, Ascherio A (2008) Familial aggregation of Parkinson’s disease: a meta-analysis. Mov Disord 23:1174–1183CrossRefPubMed
21.
Zurück zum Zitat Vidal JS, Vidailhet M, Derkinderen P, de Gaillarbois TD, Tzourio C, Alperovitch A (2009) Risk factors for progressive supranuclear palsy: a case-control study in France. J Neurol Neurosurg Psychiatry 80:1271–1274CrossRefPubMed Vidal JS, Vidailhet M, Derkinderen P, de Gaillarbois TD, Tzourio C, Alperovitch A (2009) Risk factors for progressive supranuclear palsy: a case-control study in France. J Neurol Neurosurg Psychiatry 80:1271–1274CrossRefPubMed
22.
Zurück zum Zitat Vidal JS, Vidailhet M, Elbaz A, Derkinderen P, Tzourio C, Alperovitch A (2008) Risk factors of multiple system atrophy: a case-control study in French patients. Mov Disord 23:797–803CrossRefPubMed Vidal JS, Vidailhet M, Elbaz A, Derkinderen P, Tzourio C, Alperovitch A (2008) Risk factors of multiple system atrophy: a case-control study in French patients. Mov Disord 23:797–803CrossRefPubMed
23.
Zurück zum Zitat Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58:160–166CrossRefPubMed Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58:160–166CrossRefPubMed
24.
Zurück zum Zitat Wenning GK, Wagner S, Daniel S, Quinn NP (1993) Multiple system atrophy: sporadic or familial? Lancet 342:681CrossRef Wenning GK, Wagner S, Daniel S, Quinn NP (1993) Multiple system atrophy: sporadic or familial? Lancet 342:681CrossRef
25.
Zurück zum Zitat Wullner U, Abele M, Schmitz-Huebsch T, Wilhelm K, Benecke R, Deuschl G, Klockgether T (2004) Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 75:924–925CrossRefPubMed Wullner U, Abele M, Schmitz-Huebsch T, Wilhelm K, Benecke R, Deuschl G, Klockgether T (2004) Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 75:924–925CrossRefPubMed
Metadaten
Titel
Familial aggregation in atypical Parkinson’s disease: a case control study in multiple system atrophy and progressive supranuclear palsy
verfasst von
Jean-Sébastien Vidal
Marie Vidailhet
Pascal Derkinderen
Christophe Tzourio
Annick Alpérovitch
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 8/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5638-9

Weitere Artikel der Ausgabe 8/2010

Journal of Neurology 8/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.